Advocacy in Eye Care: How to Get Involved and Make a Difference

 

 

On this thought-provoking episode of ECP Viewpoints, host Dr. Jennifer Palombi is joined by fellow optometrists Dr. Pamela Lowe and Dr. Melanie Fragoso to delve into the multifaceted world of advocacy in eye care.

The episode unfolds as Dr. Lowe and Dr. Fragoso share their personal advocacy stories, illustrating how their efforts have fortified both their profession and patient outcomes. They reveal that advocacy can spring from diverse actions. From the intimacy of the exam room, where patient education happens, to the broader expanse of legislative activities, each act of advocacy is significant.

The conversation underscores that supporting advocacy groups, financially or otherwise, is another powerful way of bolstering the profession.

Crucially, this episode provides practical advice for those new to advocacy or those feeling unsure about their expertise. Dr. Lowe and Dr. Fragoso assure listeners that everyone, regardless of comfort or experience level, can make a difference in eye care advocacy.

Key discussion points:
1. The personal advocacy journeys of Dr. Lowe and Dr. Fragoso.
2. Various forms of advocacy: from patient education to legislative participation.
3. The importance of supporting advocacy organizations.
4. Guidance for those new to advocacy activities.

As Dr. Lowe succinctly puts it: “Every patient encounter is a chance to advocate for eye health.”

Recent Episodes

The data center industry is being redefined by AI’s demand for faster, denser, and more scalable infrastructure. According to McKinsey, average rack power densities have more than doubled in just two years. It went from approximately 8 kW to 17 kW, and is expected to hit 30 kW by 2027. Global data center power demand is projected…

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…